Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

D. C. Tkachuk, C. A. Westbrook, M. Andreeff, T. A. Donlon, M. L. Cleary, K. Suryanarayan, M. Homge, A. Redner, J. Gray, D. Pinkel

Research output: Contribution to journalArticlepeer-review

359 Scopus citations


Chronic myelogeneous leukemia (CML) is genetically characterized by fusion of the bcr and abl genes on chromosomes 22 and 9, respectively. In most cases, the fusion involves a reciprocal translocation t(9;22)(q34;q11), which produces the cytogenetically distinctive Philadelphia chromosome (Ph1). Fusion can be detected by Southern (DNA) analysis or by in vitro amplification of the messenger RNA from the fusion gene with polymerase chain reaction (PCR). These techniques are sensitive but cannot be applied to single cells. Two-color fluorescence in situ hybridization (FISH) was used with probes from portions of the bcr and abl genes to detect the bcr-abl fusion in individual blood and bone marrow cells from six patients. The fusion event was detected in all samples analyzed, of which three were cytogenetically Ph1-negative. One of the Ph1-negative samples was also PCR-negative. This approach is fast and sensitive, and provides potential for determining the frequency of the abnormality in different cell lineages.

Original languageEnglish (US)
Pages (from-to)559-562
Number of pages4
Issue number4980
StatePublished - Oct 26 1990
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization'. Together they form a unique fingerprint.

Cite this